Volume, neuron density and total neuron number in five subcortical regions in schizophrenia

Brain

Volumn 130, Issue 3, 2007, Pages 678-692

  Kreczmanski, Pawel ^a,b   Heinsen, Helmut ^c   Mantua, Valentina ^a,f,g   Woltersdorf, Fritz ^d   Masson, Thorsten ^e   Ulfig, Norbert ^d   Schmidt Kastner, Rainald ^a   Korr, Hubert ^a,b,e   Steinbusch, Harry W M ^a,b   Hof, Patrick R ^h   Schmitz, Christoph ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b European Graduate School of Neuroscience   (Netherlands)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d UNIVERSITY OF ROSTOCK   (Germany)

^e RWTH AACHEN UNIVERSITY   (Germany)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

^h MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Amygdala; Design based stereology; Schizophrenia; Striatum; Thalamus

Indexed keywords

ADULT; AMYGDALOID NUCLEUS; ARTICLE; BRAIN CORTEX; BRAIN NERVE CELL; BRAIN SIZE; CADAVER; CAUDATE NUCLEUS; CELL COUNT; CELL DENSITY; CONTROLLED STUDY; CYTOPATHOLOGY; HEMISPHERE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; NEUROPATHOLOGY; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; STEREOLOGY; THALAMUS DORSOMEDIAL NUCLEUS;

ADULT; AMYGDALA; CADAVER; CAUDATE NUCLEUS; CELL COUNT; HUMANS; MALE; MEDIODORSAL THALAMIC NUCLEUS; MIDDLE AGED; NEURONS; NUCLEUS ACCUMBENS; PROSENCEPHALON; PUTAMEN; SCHIZOPHRENIA; TIME FACTORS;

EID: 33947115405     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awl386     Document Type: Article

References (96)

1. Abi-Dargham A, Rodenhiser J, Printz D, Zea-Ponce Y, Gil R, Kegeles LS, et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. Proc Natl Acad Sci USA 2000; 97: 8104-9.
2. Aleman A, Kahn RS. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia? Prog Neurobiol 2005; 77: 283-98.
3. Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990; 85: 119-46.
4. Andreasen NC, Arndt S, Swayze V II, Cizadlo T, Flaum M, O'Leary D, et al. Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging. Science 1994; 266: 294-8.
5. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry 1999; 46: 908-20.
6. Ashe PC, Berry MD, Boulton AA. Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog Neuropsychopharmacol Biol Psychiatry 2001; 25: 691-707.
7. Beckmann H, Lauer M. The human striatum in schizophrenia. II. Increased number of striatal neurons in schizophrenics. Psychiatry Res 1997; 68: 99-109.
8. Benes FM. Schizophrenia, II: amygdalar fiber alteration as etiology? Am J Psychiatry 2003; 160: 1053.
9. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 1997; 7: 740-8.
10. Bogerts B. Zur Neuropathologie der Schizophrenien. Fortschr Neurol Psychiatr 1984; 52: 428-37.
11. Bogerts B. The temporolimbic system theory of positive schizophrenic symptoms. Schizophr Bull 1997; 23: 423-35.
12. Bouwmeester H, Wolterink G, van Ree JM. Neonatal development of projections from the basolateral amygdala to prefrontal, striatal, and thalamic structures in the rat. J Comp Neurol 2002; 442: 239-49.
13. Braak H, Braak E. Neuronal types in the basolateral amygdaloid nuclei of man. Brain Res Bull 1983; 11: 349-65.
14. Braak H, Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging 1995; 16: 271-8.
15. Brockhaus H. Zur feineren Anatomie des Septum und des Striatum. J Psychol Neurol 1942; 5: 1-56.
16. Byne W, Buchsbaum MS, Mattiace LA, Hazlett EA, Kemether E, Elhakem SL, et al. Postmortem assessment of thalamic nuclear volumes in subjects with schizophrenia. Am J Psychiatry 2002; 159: 59-65.
17. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML. Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 2001; 41: 237-60.
18. Casanova MF, de Zeeuw L, Switala A, Kreczmanski P, Korr H, Ulfig N, et al. Mean cell spacing abnormalities in the neocortex of patients with schizophrenia. Psychiatry Res 2005; 133: 1-12.
19. Cavalieri B. Geometria indivisibilibus continuorum. Typis Clementis Ferronij, Bononiae, 1635 (reprinted 1966 as Geometria Degli Indivisibili. Unione Tipografico-Editrice Torinese, Torino).
20. Chakos MH, Lieberman JA, Bilder RM, Borenstein M, Lerner G, Bogerts B, et al. Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs. Am J Psychiatry 1994; 151: 1430-6.
21. Chance SA, Esiri MM, Crow TJ. Amygdala volume in schizophrenia: post-mortem study and review of magnetic resonance imaging findings. Br J Psychiatry 2002; 180: 331-8.
22. Church SM, Cotter D, Bramon E, Murray RM. Does schizophrenia result from developmental or degenerative processes? J Neural Transm Suppl 2002; 63: 129-47.
23. Crow TJ. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophren Bull 1990; 16: 433-43.
24. Crow TJ. Schizophrenia as failure of hemispheric dominance for language. Trends Neurosci 1997; 20: 339-43.
25. Cullen TJ, Walker MA, Parkinson N, Craven R, Crow TJ, Esiri MM, et al. A postmortem study of the mediodorsal nucleus of the thalamus in schizophrenia. Schizophr Res 2003; 60: 157-66.
26. Cullen TJ, Walker MA, Eastwood SL, Esiri MM, Harrison PJ, Crow TJ. Anomalies of asymmetry of pyramidal cell density and structure in dorsolateral prefrontal cortex in schizophrenia. Br J Psychiatry 2006; 188: 26-31.
27. Cunningham MG, Bhattacharyya S, Benes FM. Amygdalo-cortical sprouting continues into early adulthood: implications for the development of normal and abnormal function during adolescence. J Comp Neurol 2002; 453: 116-30.
28. Danos P, Schmidt A, Baumann B, Bernstein HG, Northoff G, Stauch R, et al. Volume and neuron number of the mediodorsal thalamic nucleus in schizophrenia: a replication study. Psychiatry Res 2005; 140: 281-9.
29. Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, et al. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Arch Gen Psychiatry 2003; 60: 443-56.
30. Dewulf A. Anatomy of the normal human thalamus: topometry and standardized nomenclature. Amsterdam: Elsevier; 1971.
31. Dorph-Petersen KA, Pierri JN, Sun Z, Sampson AR, Lewis DA. Stereological analysis of the mediodorsal thalamic nucleus in schizophrenia: volume, neuron number, and cell types. J Comp Neurol 2004; 472: 449-62.
32. Frazier JA, Giedd JN, Kaysen D, Albus K, Hamburger S, Alaghband-Rad J, et al. Childhood-onset schizophrenia: brain MRI rescan after 2 years of clozapine maintenance treatment. Am J Psychiatry 1996; 153: 564-6.
33. Friston KJ. Schizophrenia and the disconnection hypothesis. Acta Psychiatr Scand Suppl 1999; 395: 68-79.
34. Fudge JL, Emiliano AB. The extended amygdala and the dopamine system: another piece of the dopamine puzzle. J Neuropsychiatry Clin Neurosci 2003; 15: 301-16.
35. Fudge JL, Kunishio K, Walsh P, Richard C, Haber SN. Amygdaloid projections to ventromedial striatal subterritories in the primate. Neuroscience 2002; 110: 257-75.
36. Gundersen HJG, Jensen EB. The efficiency of systematic sampling and its prediction. J Microsc 1987; 147: 229-63.
37. Haber SN, Fudge JL. The interface between dopamine neurons and the amygdala: implications for schizophrenia. Schizophr Bull 1997; 23: 471-82.
38. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain 1999; 122: 593-624.
39. Harrison PJ, Owen MJ. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 2003; 361: 417-9.
40. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 2005; 10: 40-68.
41. Heckers S, Heinsen H, Heinsen YC, Beckmann H. Limbic structures and lateral ventricle in schizophrenia. A quantitative postmortem study. Arch Gen Psychiatry 1990; 47: 1016-22.
42. Heinsen H, Heinsen YL. Serial thick, frozen, gallocyanin stained sections of human central nervous system. J Histotechnol 1991; 14: 167-73.
43. Heinsen H, Beckmann H, Heinsen YL, Gallyas F, Haas S, Scharff G. Laminar neuropathology in Alzheimer's disease by a modified Gallyas impregnation. Psychiatry Res 1989; 29: 463-5.
44. Heinsen H, Henn R, Eisenmenger W, Gotz M, Bohl J, Bethke B, et al. Quantitative investigations on the human entorhinal area: left - right asymmetry and age-related changes. Anat Embryol 1994; 190: 181-94.
45. Heinsen H, Rüb U, Bauer M, Ulmar G, Bethke B, Schüler M, et al. Nerve cell loss in the thalamic mediodorsal nucleus in Huntington's disease. Acta Neuropathol 1999; 97: 613-22.
46. Heinsen H, Arzberger T, Schmitz C. Celloidin mounting (embedding without infiltration) - a new, simple and reliable method for producing serial sections of high thickness through complete human brains and its application to stereological and immunohistochemical investigations. J Chem Neuroanat 2000; 20: 49-59.
47. Hirai T, Jones EG. A new parcellation of the human thalamus on the basis of histochemical staining. Brain Res Rev 1989; 14: 1-34.
48. Holt DJ, Herman MM, Hyde TM, Kleinman JE, Sinton CM, German DC, et al. Evidence for a deficit in cholinergic interneurons in the striatum in schizophrenia. Neuroscience 1999; 94: 21-31.
49. Honea R, Crow TJ, Passingham D, Mackay CE. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 2005; 162: 2233-45.
50. Jones EG. A description of the human thalamus. In: Steriade M, Jones EG, McCormick DA, editors. Experimental and clinical aspects. Thalamus, Vol. II. Oxford: Elsevier Science; 1997. p. 425-500.
51. Kasai K, Iwanami A, Yamasue H, Kuroki N, Nakagome K, Fukuda M. Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 2002; 43: 93-110.
52. Kemether EM, Buchsbaum MS, Byne W, Hazlett EA, Haznedar M, Brickman AM, et al. Magnetic resonance imaging of mediodorsal, pulvinar, and centromedian nuclei of the thalamus in patients with schizophrenia. Arch Gen Psychiatry 2003; 60: 983-91.
53. Kendler KS. "A gene for . . .." The nature of gene action in psychiatric disorders. Am J Psychiatr 2005; 162: 1243-52.
54. Kirov G, O'Donovan MC, Owen MJ. Finding schizophrenia genes. J Clin Invest 2005; 115: 1440-8.
55. Kreczmanski P, Schmidt-Kastner R, Heinsen H, Steinbusch HW, Hof PR, Schmitz C. Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathol 2005; 109: 510-8.
56. Lang DJ, Kopala LC, Vandorpe RA, Rui Q, Smith GN, Goghari VM, et al. Reduced basal ganglia volumes after switching to olanzapine in chronically treated patients with schizophrenia. Am J Psychiatry 2004; 161: 1829-36.
57. Lauer M, Heinsen H. Cytoarchitectonics of the human nucleus accumbens. J Hirnforsch 1996; 37: 243-54.
58. Lauer M, Beckmann H. The human striatum in schizophrenia. I. Increase in overall relative striatal volume in schizophrenics. Psychiatry Res 1997; 68: 87-98.
59. Lauer M, Senitz D, Beckmann H. Increased volume of the nucleus accumbens in schizophrenia. J Neural Transm 2001; 108: 645-60.
60. Lawrie SM, Abukmeil SS. Brain abnormality in schizophrenia. A systematic and quantitative review of volumetric magnetic resonance imaging studies. Br J Psychiatry 1998; 172: 110-20.
61. Lewis DA, Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002; 25: 409-32.
62. Lieberman JA. Is schizophrenia a neurodegenerative disorder? A clinical and neurobiological perspective. Biol Psychiatry 1999; 46: 729-39.
63. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biol Psychiatry 1999; 45: 1099-119.
64. Murray RM, Sham P, Van Os J, Zanelli J, Cannon M, McDonald C. A developmental model for similarities and dissimilarities between schizophrenia and bipolar disorder. Schizophrenia Res 2004; 71: 405-16.
65. Nelson MD, Saykin AJ, Flashman LA, Riordan HJ. Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging: a meta-analytic study. Arch Gen Psychiatry 1998; 55: 433-40.
66. Owen MJ, Williams NM, O'Donovan MC. The molecular genetics of schizophrenia: new findings promise new insights. Mol Psychiatry 2004; 9: 14-27.
67. Pakkenberg B. Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics. Arch Gen Psychiatry 1990; 47: 1023-8.
68. Popken GJ, Bunney WE, Potkin SG, Jones EG. Subnucleus-specific loss of neurons in medial thalamus of schizophrenics. Proc Natl Acad Sci USA 2000; 97: 9276-80.
69. Petty RG. Structural asymmetries of the human brain and their disturbance in schizophrenia. Schizophren Bull 1999; 25: 121-39.
70. Savander V, Miettinen R, Ledoux JE, Pitkänen A. Lateral nucleus of the rat amygdala is reciprocally connected with basal and accessory basal nuclei: a light and electron microscopic study. Neuroscience 1997; 77: 767-81.
71. Sawa A, Snyder SH. Schizophrenia: diverse approaches to a complex disease. Science 2002; 296: 692-5.
72. Schmidt-Kastner R, van Os J, Steinbusch HWM, Schmitz C. Gene regulation by hypoxia and the neurodevelopmental origin of schizophrenia. Schizophr Res 2006; 84: 253-71.
73. Schmitz C. Variation of fractionator estimates and its prediction. Anat Embryol 1998; 198: 371-97.
74. Schmitz C, Hof PR. Recommendations for straightforward and rigorous methods of counting neurons based on a computer simulation approach. J Chem Neuroanat 2000; 20: 93-114.
75. Schmitz C, Hof PR. Design-based stereology in neuroscience. Neuroscience 2005; 130: 813-31.
76. Schmitz C, Grolms N, Hof PR, Boehringer R, Glaser J, Korr H. Altered spatial arrangement of layer V pyramidal cells in the mouse brain following prenatal low-dose X-irradiation. A stereological study using a novel three-dimensional analysis method to estimate the nearest neighbor distance distributions of cells in thick sections. Cereb Cortex 2002; 12: 954-60.
77. Stereological estimation of the number of neurons in the human amygdaloid complex. J Comp Neurol 2005; 491: 320-9, 2006; 494: 704.
78. Schumann CM, Amaral DG. Stereological analysis of amygdala neuron number in autism. J Neurosci 2006; 26: 7674-9.
79. Selemon LD. Regionally diverse cortical pathology in schizophrenia: clues to the etiology of the disease. Schizophren Bull 2001; 27: 349-77.
80. Shenton ME, Dickey CC, Frumin M, McCarley RW. A review of MRI findings in schizophrenia. Schizophren Res 2001; 49: 1-52.
81. Sims KS, Williams RS. The human amygdaloid complex: a cytologic and histochemical atlas using Nissl, myelin, acetylcholinesterase and nicotinamide adenine dinucleotide phosphate diaphorase staining. Neuroscience 1990; 36: 449-72.
82. Sorvari H, Soininen H, Pitkanen A. Calbindin-D28K-immunoreactive cells and fibres in the human amygdaloid complex. Neuroscience 1996; 75: 421-43.
83. Stephan KE, Baldeweg T, Friston KJ. Synaptic plasticity and dysconnection in schizophrenia. Biol Psychiatry 2006; 59: 929-39.
84. Tamminga CA, Vogel M, Gao X, Lahti AC, Holcomb HH. The limbic cortex in schizophrenia: focus on the anterior cingulate. Brain Res Rev 2000; 31: 364-70.
85. Thune JJ, Pakkenberg B. Stereological studies of the schizophrenic brain. Brain Res Rev 2000; 31: 200-4.
86. Tsuang MT. Schizophrenia: genes and environment. Biol Psychiatry 2000; 47: 210-20.
87. Weinberger DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44: 660-9.
88. Weinberger DR. The biological basis of schizophrenia: new directions. J Clin Psychiatry 1997; 58 Suppl 10: 22-7.
89. West MJ, Slomianka L, Gundersen HJ. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anat Rec 1991; 231: 482-97.
90. Winterer G, Weinberger DR. Genes, dopamine and cortical signal-to-noise ratio in schizophrenia. Trends Neurosci 2004; 27: 683-90.
91. Wolterink G, Daenen LE, Dubbeldam S, Gerrits MA, van Rijn R, Kruse CG, et al. Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur Neuropsychopharmacol 2001; 11: 51-9.
92. Wright IC, Rabe-Hesketh S, Woodruff PW, David AS, Murray RM, Bullmore ET. Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 2000; 157: 16-25.
93. Yaniv D, Desmedt A, Jaffard R, Richter-Levin G. The amygdala and appraisal processes: stimulus and response complexity as an organizing factor. Brain Res Rev 2004; 44: 179-86.
94. Young KA, Manaye KF, Liang C, Hicks PB, German DC. Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia. Biol Psychiatry 2000; 47: 944-53.
95. Zipursky RB, Lim KO, Sullivan EV, Brown BW, Pfefferbaum A. Widespread cerebral gray matter volume deficits in schizophrenia. Arch Gen Psychiatry 1992; 49: 195-205.
96. Zipursky RB, Seeman MV, Bury A, Langevin R, Wortzman G, Katz R. Deficits in gray matter volume are present in schizophrenia but not bipolar disorder. Schizophr Res 1997; 26: 85-92.